Q4 2024 Management View CEO Kipp DeVeer announced leadership changes, with Kort Schnabel assuming the role of Chief Executive Officer effective April 30, 2025. DeVeer will remain involved as a member ...
RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...
Shares of Novo Nordisk ( NVO 4.37%) were moving higher on Wednesday. The company's stock gained 4.9% as of 1:50 p.m. ET, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback